ProShares UltraShort Health Care
3 hedge funds and large institutions have $293K invested in ProShares UltraShort Health Care in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
2,690% more capital invested
Capital invested by funds: $10.5K → $293K (+$282K)
160% more call options, than puts
Call options by funds: $63.7M | Put options by funds: $24.5M
14.07% more ownership
Funds ownership: 0.28% → 14.35% (+14%)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
+$265K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$38.6K |
| 3 |
Morgan Stanley
New York
|
+$22 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Cutler Group
San Francisco,
California
|
-$1K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$12 |
RXD Hedge Fund Activity: Q1 2024 in Review
3 of the 6,957 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q1 2024, worth a combined $293K — up 2,690% from $10.5K a quarter earlier.
Fund positioning in RXD was balanced in Q1 2024: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was IMC Chicago, opening a new position worth an estimated $265K. The largest seller was Cutler Group, exiting entirely with an estimated $1K sold.
- 3 institutional investors held ProShares UltraShort Health Care (RXD) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $293K of ProShares UltraShort Health Care stock for Q1 2024, up 2,690% quarter-over-quarter.
- 2 funds opened new ProShares UltraShort Health Care positions in Q1 2024 and 2 closed out, a net change of 0 holders.
- The largest ProShares UltraShort Health Care buyer in Q1 2024 was IMC Chicago, an estimated $265K added.
- The largest ProShares UltraShort Health Care seller in Q1 2024 was Cutler Group, an estimated $1K sold.
Based on aggregated 13F filings for Q1 2024.